Live from the NIH registry
Studies recruiting near Tucson right now
Top 25 of 485 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Pima Heart and Vascular — Tucson, Arizona (5.4 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Lupus Research Alliance
A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
Cancer
N/A
Interventional 30 participants sought
University of Arizona Cancer Center — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Tucson, Arizona (5.4 mi)
· Sponsor: Sameek Roychowdhury
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Del Sol Research Management, LLC — Tucson, Arizona (5.4 mi)
· Sponsor: Ardelyx
Therapy for Adverbial Clauses
Developmental Language Disorder
N/A
Interventional 16 participants sought
Department of Speech, Language & Hearing Sciences, University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: Children's Oncology Group
The Effect of Semantic Support on Word Learning
Language Development Disorders
N/A
Interventional 32 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
University of Arizona Cancer Center ( Site 0035) — Tucson, Arizona (5.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
HER2/Neu+ Uterine Serous Carcinoma
Phase 2
Interventional 50 participants sought
University of Arizona Cancer Center — Tucson, Arizona (5.4 mi)
· Sponsor: Yale University
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Refractory Angina
N/A
Interventional 380 participants sought
University of Arizona Sarver Heart Center — Tucson, Arizona (5.4 mi)
· Sponsor: Shockwave Medical, Inc.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 410 participants sought
The University of Arizona Cancer Center — Tucson, Arizona (5.4 mi)
· Sponsor: AVEO Pharmaceuticals, Inc.
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Tucson Cystic Fibrosis Center — Tucson, Arizona (5.4 mi)
· Sponsor: Nicole Hamblett
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
SLE, SLE (Systemic Lupus)
Phase 1
Interventional 24 participants sought
AARA Clinical Research — Tucson, Arizona (5.4 mi)
· Sponsor: Cullinan Therapeutics Inc.
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Local Institution - 0205 — Tucson, Arizona (5.4 mi)
· Sponsor: Bristol-Myers Squibb
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 231 participants sought
Site Number - 1042 — Tucson, Arizona (5.4 mi)
· Sponsor: Immunovant Sciences GmbH
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: Axsome Therapeutics, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
Breast Cancer
N/A
Interventional 600 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Enhancing Language Function in Aphasia
Aphasia, Acquired, Language Disorders
N/A
Interventional 30 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Adobe Clinical Research — Tucson, Arizona (5.4 mi)
· Sponsor: Regeneron Pharmaceuticals
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome, Respiratory Failure
Phase 3
Interventional 1,100 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Beth Israel Deaconess Medical Center